<DOC>
	<DOCNO>NCT00004992</DOCNO>
	<brief_summary>The Diabetes Prevention Program nationwide clinical study answer question : Can Type 2 diabetes ( also call noninsulin-dependent adult-onset diabetes ) prevent delay ? The study recruit 3819 volunteer , high risk develop diabetes , twenty-five medical center United States . It sponsor National Institute Diabetes Digestive Kidney Diseases National Institutes Health , Institute corporate sponsor . Researchers evaluate efficacy lifestyle intervention pharmacological intervention prevent delay Type 2 diabetes person IGT , impair glucose tolerance . Each person study follow 3 6 year .</brief_summary>
	<brief_title>Diabetes Prevention Program</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>Impaired glucose tolerance ( FPG 95125 mg/dL 2hr PG 140199 mg/dL ) BMI &gt; = 24 kg/m2 Underlying disease likely limit life span and/or increase risk intervention Conditions behavior likely effect conduct DPP Diabetes disorder glucose metabolism Suboptimally treat Thyroid disease Fasting triglyceride level &lt; 600 mg/dl Exclusions related medication</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>clinical trial</keyword>
	<keyword>multi-center</keyword>
	<keyword>NIDDM</keyword>
	<keyword>NIDDK</keyword>
	<keyword>DPP</keyword>
	<keyword>diabetes risk factor</keyword>
	<keyword>diabetes</keyword>
	<keyword>glycemia</keyword>
	<keyword>cardiovascular risk factor</keyword>
	<keyword>quality life</keyword>
	<keyword>physical activity nutrition</keyword>
	<keyword>occurrence adverse event</keyword>
	<keyword>insulin secretion sensitivity</keyword>
	<keyword>prevention</keyword>
	<keyword>abnormal glucose metabolism</keyword>
	<keyword>lifestyle intervention</keyword>
	<keyword>drug intervention</keyword>
</DOC>